Pages that link to "Q37392045"

The following pages link to Experimental animal model and RNA interference: a promising association for bladder cancer research. (Q37392045):

Displaying 15 items.

• Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition (Q34477376) (← links)
• Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer (Q36127825) (← links)
• MicroRNAs: a new paradigm on molecular urological oncology. (Q37753387) (← links)
• Animal models of urinary bladder cancer and their application to novel drug discovery (Q38199547) (← links)
• Animal models for bladder cancer: The model establishment and evaluation (Review). (Q38383646) (← links)
• Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line (Q38736621) (← links)
• Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool (Q39692014) (← links)
• A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma (Q39717326) (← links)
• Evolution on experimental animal model for upper urothelium carcinogenesis (Q39885213) (← links)
• Insights from animal models of bladder cancer: recent advances, challenges, and opportunities (Q41339763) (← links)
• The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model (Q50182629) (← links)
• Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model (Q51731965) (← links)
• Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer. (Q55319024) (← links)
• Chorioallantoic urothelial tumor avatar. A clinical tool for phenotype-based therapy (Q89674984) (← links)
• Conditional reprogramming: Modeling urological cancer and translation to clinics (Q96167204) (← links)